Download Free Medical Abnormal uterine bleeding PowerPoint Presentation

Abnormal uterine bleeding PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Obstetrics & Gynecology, which is titled "Abnormal uterine bleeding", to know about the bleeding that is not regular cyclic menstrual flow, intermenstrual spotting, post coital bleeding, excessively heavy bleeding, and unpredictable bleeding.

Tags : Obstetrics, Gynecology, Abnormal uterine bleeding, cyclic menstrual flow, intermenstrual spotting, post coital bleeding, excessively heavy bleeding, unpredictable bleeding

Published on : Jul 18, 2021 | Views : 2191 | Downloads : 18

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Abnormal uterine bleeding Nancy E Fay MD FACOG Division of Reproductive Medicine
Slide 2-

Definition-AUB Any bleeding that is not regular cyclic menstrual flow Intermenstrual spotting Post coital bleeding Excessively heavy bleeding Unpredictable bleeding
Slide 3-

PALM-COIEN Classification PALM-Structural causes Polyp (AUB-P) Adenomyosis (AUB-A) Leiomyoma (AUB-L) Sub mucosal Intramural Malignancy/hyperplasia(AUB-M)
Slide 4-

PALM-COEIN Classification COEIN: Nonstructural causes Coagulopathy (AUB-C) Ovulatory dysfunction (AUB-O) Endometrial (AUB-E) Iatrogenic (AUB-I) Not yet classified (AUB-N)
Slide 5-

Physiology of the menstrual cycle Proliferative or follicular phase Endometrium Height starts <5 mm to <15 mm Mitotic growth of tubular glands response to rising estrogen
Slide 6-

Follicular phase *Primordial follicles develop INDEPENDENT of FSH Estradiol promotes FSH receptors Ends with LH surgeand meiosis of dominant follicle
Slide 7-

Secretory or luteal phase Endometrium Stromal height fixed, becomes edematous Glands tortuous, sub nuclear vacuoles Arteries spiral Endometrium stratified into basalis 25%, spongiosa 50% and outer compacta 25% Endometrial biopsy to date endometrium; luteal insufficiency. Timed progesterone alternative
Slide 8-

Secretory or luteal phase Ovary LH surge causes reduction division of oocyte Growth of granulosa cells in size, #’s and metabolic activity Day 8 capillary growth and progesterone peak If no HCG to stimulate, follicular atresia begins *Progesterone suppresses new follicular growth
Slide 9-

Luteal or secretory phase
Slide 10-

Menstrual phase Steroid withdrawal causes lysosomal instability releasing prostaglandin synthetase, proteases and collagenases High thromboxane A2 results in vasospasm and ischemic necrosis of the endometrium at the level of basalis layer Endometrial healing by rising estrogen from new follicles with estradiol mediated growth
Slide 11-

Adolescent development Average development Breast bud 9.8 yrs Pubic hair 10.5 yrs Maximal growth velocity 11.4 yrs Menarche at 12.8 yrs Adult pubic hair by 13.4 yrs Adult breast by 14.6 yrs
Slide 12-

Adolescent development 55% of cycles first year are anovulatory Usually at least 15 months from menarche to achieve 10 cycles Normal fertile adults have 1-2 anovulatory and 10-12 cycles per year Adolescent menstrual pattern ends 2-3 yrs after menarche
Slide 13-

Tanner Stages
Slide 14-

Adolescent AUB, persistent 10% with menorrhagia will have coagulopathy Most common are ITP, Von Willebrand’s, Glanzmann's, Thalassemia major and Fanconi’s anemia Tests: INR, PTT, bleeding time, platelet count and VonWillebrand’s screen
Slide 15-

Other terms Polymenorrhea; frequent cycles <18 days Metrorrhagia; intermittent intermenstrual bleeding Menorrhagia; regular but excessively heavy flow Menometrorrhagia; irregular, frequent, heavy and light bleeding Hypomenorrhea; light flow at regular intervals Oligomenorrhea; irregular, infrequent cycles >45 days apart, ovulatory or anovulatory
Slide 16-

Average menses Estrogen + progesterone withdrawal 5 day flow (2-8 normal) Volume loss 30 cc (>80 cc abnormal) Average cycle range 21-35 days
Slide 17-

Menstrual cycle Mature follicle 2-2.5 cm size Corpus luteum complex cyst 1-3 cm size Endometrial height range 3-14 mm
Slide 18-

Causes of anovulation (AUB-O) Physiologic: adolescence, perimenopause, lactation and pregnancy Pathologic Hyperandrogenic Hypothalamic Thyroid disease Primary pituitary Premature ovarian failure Medications/herbal supplements
Slide 19-

History the most important Qualify and quantify bleeding: type of protection, frequency of change saturation, clotting Establish current complaint and find out what ‘normal’ menses usually are like OFF any hormonal contraceptives (many women don’t think of hormonal contraceptives as a medication) Other symptoms such as cramping, dyspareunia Evaluate use of medications prescriptive as well as OTC and herbal supplements
Slide 20-

Pregnancy ALWAYS check HCG
Slide 21-

Polycystic ovary syndrome Affects 1 in 9 women Most common cause of anovulation Diagnosis, Oligo or anovulation with one of: Evidence of androgen excess Polycystic ovary Begins in teen years or early twenties Multifactorial inheritance associated with insulin resistance and metabolic syndrome. Family history of type II DM
Slide 22-

PCOS Need to treat proactively with OCP’s, cyclic progesterone to decrease their risk of endometrial cancer from unopposed estrogen For fertility purposes, use of insulin sensitizers (metformin) may decrease insulin resistance enough to allow ovulation along with low carb diet and exercise. Ideal body weight the goal. Otherwise ovulation induction needed to conceive. Milder cases of PCOS ovulatory, low progesterone, and have a higher risk of miscarriage
Slide 23-

PCOS Associated with thyroid dysfunction. Hirsutism treated with spironolactone and OCP’s Endometrial biopsy? When needed?
Slide 24-

Hypothalamic dysfunction Hyper or hypothyroidism Age factor in screening >35 hypo Hyperprolactinemia Amenorrhea or hypomenorrhea 2/3 Galactorrhea present in 1/3 Infertility with normal menses Need repeat >48 hrs apart to confirm Level >50 need to consider MRI of sella
Slide 25-

Hypothalamic dysfunction CNS suppression, low FSH and LH Stress most common cause Anorexia Athletic Lower suppression higher estradiol, more suppression hypoestrogenic Rare congenital absence of LH or mutation in gonadotropins or GnRH (the latter primary amenorrhea)
Slide 26-

Coagulation disorder Most common causes are ITP, VonWillebrand’s, Glanzman’s, Thallasemia major or Fanconi’s anemia Test for bleeding time, INR, PTT, platelet count and VonWillebrand’s screen Remember if severely anemic testing skewed In adolescents 10% will have coagulopathy Usually ovulatory cycles with severe menorrhagia Tranexamic acid may be of benefit for some
Slide 27-

Chromosome disorders Suspect if initial normal cycles then irregular or amenorrhea and evidence of diminished reserve <25 y/o Turner mosaic more likely Later 20’s to early mid 30’s diminished reserve associated with Fragile X pre-mutation or on the older end BRCA 1 mutation If mutation and some reserve left consider ART options: gamete freezing, IVF with PGD Otherwise fertility with donor eggs and use of HRT or OCP’s as replacement therapy till 50
Slide 28-

Anatomic causes of AUB Endometrial polyp Sub mucus fibroid
Slide 29-

Ovarian masses Endomctrioma Hormone secreting tumors PID
Slide 30-

Malignancies Endometrial cancer What age should you biopsy to rule out? Endometrial hyperplasia Simple Complex adenomatous Atypical complex Ovarian
Slide 31-

Treatment of AUB Anatomic causes treat and usually bleeding controlled. If not likely hormone issue Thyroid dysfunction treatment will resolve AUB once normal functions after 2 months Hyperprolactinemia treat with cabergoline or bromocriptine. When prolactin normal, normal menses in 2 cycles If unable to treat cause then cyclic progestins or hormonal contraceptives best treatment.
Slide 32-

Treatment of hemorrhage Usually at extremes of menstrual ages Rule out pregnancy, trauma, coagulopathy; replace blood products as needed Endometrial biopsy depending on age and history High dose IV conjugated estrogen 25 mg Q4-6 hrs till bleeding slows then switch to oral estrogen and progestin. Give for 3 weeks then withdrawal. Antiemetics Oral high dose E+P an option if stable Cycle with hormonal contraceptives 2 months